Limits...
The PROactive instruments to measure physical activity in patients with chronic obstructive pulmonary disease.

Gimeno-Santos E, Raste Y, Demeyer H, Louvaris Z, de Jong C, Rabinovich RA, Hopkinson NS, Polkey MI, Vogiatzis I, Tabberer M, Dobbels F, Ivanoff N, de Boer WI, van der Molen T, Kulich K, Serra I, Basagaña X, Troosters T, Puhan MA, Karlsson N, Garcia-Aymerich J, PROactive consorti - Eur. Respir. J. (2015)

Bottom Line: Our objective was item reduction and initial validation of two instruments to measure physical activity in COPD.Physical activity was assessed in a 6-week, randomised, two-way cross-over, multicentre study using PROactive draft questionnaires (daily and clinical visit versions) and two activity monitors.After item reduction, the daily PROactive instrument comprised nine items and the clinical visit contained 14.Confirmatory factor analysis supported the bidimensional structure.

View Article: PubMed Central - PubMed

Affiliation: Centre for Research in Environmental Epidemiology (CREAL), Barcelona, Spain Centro de Investigación Biomédica en Red de Epidemiología y Salud Pública (CIBERESP), Barcelona, Spain Universitat Pompeu Fabra (UPF), Barcelona, Spain FCS Blanquerna, Research Group in Physiotherapy (GReFis), Universitat Ramon Llull, Barcelona, Spain.

No MeSH data available.


Related in: MedlinePlus

Study visits and assessments. PRO: patient-reported outcome; CRQ: chronic respiratory questionnaire; CCQ: clinical chronic obstructive pulmonary disease questionnaire; CAT: chronic obstructive pulmonary disease assessment test; HADS: hospital anxiety and depression scale; COPD: chronic obstructive pulmonary disease; mMRC: modified Medical Research Council dyspnoea scale; SAE: serious adverse event; 6MWT: 6-min walk test. #: assessments could be split between visit 1 and visit 2; ¶: in the exacerbated patients group only.
© Copyright Policy - open-access
Related In: Results  -  Collection

License
getmorefigures.php?uid=PMC4589432&req=5

Figure 1: Study visits and assessments. PRO: patient-reported outcome; CRQ: chronic respiratory questionnaire; CCQ: clinical chronic obstructive pulmonary disease questionnaire; CAT: chronic obstructive pulmonary disease assessment test; HADS: hospital anxiety and depression scale; COPD: chronic obstructive pulmonary disease; mMRC: modified Medical Research Council dyspnoea scale; SAE: serious adverse event; 6MWT: 6-min walk test. #: assessments could be split between visit 1 and visit 2; ¶: in the exacerbated patients group only.

Mentions: A 6-week, randomised, two-way cross-over, multicentre study was conducted in five European medical centres (fig. 1, further details in the online supplementary material). We recruited both stable and exacerbated patients with COPD defined by spirometry, to cover the whole range of physical activity. The study was advised and approved by the PROactive ethics and patient advisory boards, approved by the ethics committee at each centre and registered at www.clinicaltrials.gov (NCT01388218). Written consent was obtained from all patients.FIGURE 1


The PROactive instruments to measure physical activity in patients with chronic obstructive pulmonary disease.

Gimeno-Santos E, Raste Y, Demeyer H, Louvaris Z, de Jong C, Rabinovich RA, Hopkinson NS, Polkey MI, Vogiatzis I, Tabberer M, Dobbels F, Ivanoff N, de Boer WI, van der Molen T, Kulich K, Serra I, Basagaña X, Troosters T, Puhan MA, Karlsson N, Garcia-Aymerich J, PROactive consorti - Eur. Respir. J. (2015)

Study visits and assessments. PRO: patient-reported outcome; CRQ: chronic respiratory questionnaire; CCQ: clinical chronic obstructive pulmonary disease questionnaire; CAT: chronic obstructive pulmonary disease assessment test; HADS: hospital anxiety and depression scale; COPD: chronic obstructive pulmonary disease; mMRC: modified Medical Research Council dyspnoea scale; SAE: serious adverse event; 6MWT: 6-min walk test. #: assessments could be split between visit 1 and visit 2; ¶: in the exacerbated patients group only.
© Copyright Policy - open-access
Related In: Results  -  Collection

License
Show All Figures
getmorefigures.php?uid=PMC4589432&req=5

Figure 1: Study visits and assessments. PRO: patient-reported outcome; CRQ: chronic respiratory questionnaire; CCQ: clinical chronic obstructive pulmonary disease questionnaire; CAT: chronic obstructive pulmonary disease assessment test; HADS: hospital anxiety and depression scale; COPD: chronic obstructive pulmonary disease; mMRC: modified Medical Research Council dyspnoea scale; SAE: serious adverse event; 6MWT: 6-min walk test. #: assessments could be split between visit 1 and visit 2; ¶: in the exacerbated patients group only.
Mentions: A 6-week, randomised, two-way cross-over, multicentre study was conducted in five European medical centres (fig. 1, further details in the online supplementary material). We recruited both stable and exacerbated patients with COPD defined by spirometry, to cover the whole range of physical activity. The study was advised and approved by the PROactive ethics and patient advisory boards, approved by the ethics committee at each centre and registered at www.clinicaltrials.gov (NCT01388218). Written consent was obtained from all patients.FIGURE 1

Bottom Line: Our objective was item reduction and initial validation of two instruments to measure physical activity in COPD.Physical activity was assessed in a 6-week, randomised, two-way cross-over, multicentre study using PROactive draft questionnaires (daily and clinical visit versions) and two activity monitors.After item reduction, the daily PROactive instrument comprised nine items and the clinical visit contained 14.Confirmatory factor analysis supported the bidimensional structure.

View Article: PubMed Central - PubMed

Affiliation: Centre for Research in Environmental Epidemiology (CREAL), Barcelona, Spain Centro de Investigación Biomédica en Red de Epidemiología y Salud Pública (CIBERESP), Barcelona, Spain Universitat Pompeu Fabra (UPF), Barcelona, Spain FCS Blanquerna, Research Group in Physiotherapy (GReFis), Universitat Ramon Llull, Barcelona, Spain.

No MeSH data available.


Related in: MedlinePlus